This trial is testing the safety and effectiveness of etrasimod, a pill taken once daily, to treat moderate-to-severe atopic dermatitis (eczema) in adults who tried treatments that work all over the body and saw no effects. Participants will visit the clinic 6-12 times over 16-68 weeks, with tests for signs/symptoms, blood samples and vital signs.
- Atopic Dermatitis
40 Primary · 2 Secondary · Reporting Duration: Baseline up to 68 weeks in Part 1 and up to 52 weeks in Part 2
2 Treatment Groups
1 of 2
Placebo (Part 1 DB period only)
1 of 2
400 Total Participants · 2 Treatment Groups
Primary Treatment: etrasimod · Has Placebo Group · Phase 2 & 3
Who is running the clinical trial?
Age 18 - 80 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does this research require participants to be of legal age?
"The qualifications for this medical trial necessitate that participants lie between 18 and 80 years old. There are 105 trials dedicated to minors under the age of 18, and 170 specifically catering towards seniors over 65 years in age." - Anonymous Online Contributor
Does my background qualify me to partake in this experiment?
"The requirements to be admitted into this medical trial include having a diagnosis of atopic dermatitis and being between 18-80 years old. There is capacity for approximately 400 individuals to participate." - Anonymous Online Contributor
How many venues are currently hosting this clinical trial?
"Akumin Imaging in Tampa, Michigan, Clinical Research Trials of Florida in Lathrup Village, South Dakota, and Tampa Eye Clinic in Troy, Texas are among the 10 clinical sites administering this trial." - Anonymous Online Contributor
What is the present size of this research project's participant population?
"This study necessitates the inclusion of 400 eligible patients. Participants can enroll at Akumin Imaging in Tampa, Michigan and Clinical Research Trials of Florida in Lathrup Village, South Dakota." - Anonymous Online Contributor
Are there any opportunities for patient enrolment in this investigation?
"Clinicaltrials.gov confirms that recruitment for this clinical trial is ongoing, beginning on January 18th 2023 and most recently updated February 7th 2023." - Anonymous Online Contributor